Vitrolife Reduction of the Share Premium Reserve
10. März 2003 11:19 ET
|
Vitrolife
STOCKHOLM, Sweden, March 10, 2003 (PRIMEZONE) -- In order to facilitate future dividends to the shareholders, the Board of Directors has today decided to propose the ordinary general meeting May 14,...
Vitrolife's press release of annual accounts 2002
19. Februar 2003 13:44 ET
|
Vitrolife
STOCKHOLM, Feb. 19, 2003 (PRIMEZONE) -- Vitrolife announces results:
- Net total sales amounted to SEK 103.3 million (100.1)
- Revenues for core activities increased by 17.1% to a total of SEK...
Vitrolife has Launched a Savings and Restructuring Program that will be Charged to the 2002 Year's Accounts
21. Januar 2003 12:18 ET
|
Vitrolife
STOCKHOLM, Sweden, Jan. 21, 2003 (PRIMEZONE) -- Vitrolife has launched a savings and restructuring program that will be charged to the 2002 years accounts. The strategy is to focus harder on the core...
New Chief Account Officer in Vitrolife AB
20. Januar 2003 12:16 ET
|
Vitrolife
STOCKHOLM, Sweden, Jan. 20, 2003 (PRIMEZONE) -- Margareta Fischer who has worked as CAO in Vitrolife Sweden AB (publ) since the summer of 2002 has taken up the post of new chief account officer in...
Vitrolife's Interim Report, January - September 2002
22. Oktober 2002 09:28 ET
|
Vitrolife
STOCKHOLM, Sweden, October 22, 2002 (PRIMEZONE) -- Vitrolife:
- Net sales increased by 24% and amounted to 85,5 MSEK (69,1 MSEK).
- Gross profit increased by 96% and amounted to 44,7 MSEK (22,8...
Vitrolife Launches a New Cell Culture Media System for In-Vitro Fertilization, GIII Series - Closer to Nature, in the USA
15. Oktober 2002 04:38 ET
|
Vitrolife
STOCKHOLM, Sweden, Oct. 15, 2002 (PRIMEZONE) -- At the 58th Annual Meeting of the American Society for Reproductive Medicine in Seattle, Wash., October 12-17, Vitrolife introduces a new cell culture...
Vitrolife Receives FDA Marketing Approval of New Cell Culture Media for In-Vitro Fertilization - GIII Series -- Closer to Nature - Containing Recombinant Albumin and Hyaluronan
11. September 2002 03:16 ET
|
Vitrolife
GOTEBORG, Sweden, Sept. 11, 2002 (PRIMEZONE) -- The American Food and Drug Administration (FDA) has approved Vitrolife's application for market clearance, 510(k), of a new complete product line of...
Vitrolife's Interim Report, January - June 2002
15. August 2002 07:25 ET
|
Vitrolife
GOTEBORG, Sweden, August 15, 2002 (PRIMEZONE) -- Vitrolife:
- Net sales increased by 44 % and amounted to 62,5 MSEK
(43,3 MSEK).
- Gross profit increased by 113 % and...
Vitrolife has Divested Its Sales Rights to Ophthalin and Fermathron Including its Manufacturing Plant in Scotland
13. August 2002 05:45 ET
|
Vitrolife
STOCKHOLM, Sweden, Aug. 13, 2002 (PRIMEZONE) -- In conjunction with the restructuring of Vitrolife's Biosupportive Systems business area, the Company has divested the sales rights of its...
Vitrolife Opens U.S. Subsidiary for Its Cross-Linked Hyaluronan Dermal Implant Business
24. Mai 2002 05:05 ET
|
Vitrolife
STOCKHOLM, Sweden, May 24, 2002 (PRIMEZONE) -- Vitrolife has opened a U.S. subsidiary, A-Life, Inc. in Newport Beach, California, to focus on final clinical development and marketing of its double...